Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Better U Care vs Queen RX

Better U Care
Graded #239

Lower grade

vs+1.2000000000000028
Queen RX
Graded #212

Higher grade

The verdict

Queen RX takes it — 66/100 to 64.8/100, but only just.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo). Better U Care is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +28
48
76
Dose & formulationBetter U Care +28
85
57
Clinical oversightBetter U Care +5
74
69
Labs & monitoringQueen RX +1
52
53
FulfillmentQueen RX +2
73
75
Contract termsQueen RX +6
55
61
Better U Care · left barQueen RX · right bar

The numbers

MetricBetter U CareQueen RX
WeighScore64.8/10066/100
GradeCC
Scorecard rank#239#212
Semaglutide$298/mo$100/mo (quarterly plan, compounded)
Tirzepatide$397/moNot disclosed
Coverage21 states45 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Better U Care

Graded #239 · C

Strengths

  • Transparent self-pay pricing with no insurance required
  • Offers both compounded and brand-name semaglutide and tirzepatide
  • Uniform compounded pricing across all doses with supplies included
  • Publishes its full list of covered states

Where it loses points

  • Available in 21 states rather than nationwide
  • Does not name a compounding pharmacy or list an accreditation seal
  • Brand medications carry a separate 150 dollar consult fee
Queen RX

Graded #212 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard